- Home
- PROV vs XTNT Comparison
PROV vs XTNT Comparison
Compare PROV & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- XTNT
- Stock Information
- Founded
- PROV 1956
- XTNT N/A
- Country
- PROV United States
- XTNT United States
- Employees
- PROV N/A
- XTNT N/A
- Industry
- PROV Savings Institutions
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PROV Finance
- XTNT Health Care
- Exchange
- PROV Nasdaq
- XTNT Nasdaq
- Market Cap
- PROV 103.7M
- XTNT 89.8M
- IPO Year
- PROV 1996
- XTNT N/A
- Fundamental
- Price
- PROV $15.85
- XTNT $0.68
- Analyst Decision
- PROV Hold
- XTNT
- Analyst Count
- PROV 1
- XTNT 0
- Target Price
- PROV $16.50
- XTNT N/A
- AVG Volume (30 Days)
- PROV 9.4K
- XTNT 110.3K
- Earning Date
- PROV 10-27-2025
- XTNT 11-11-2025
- Dividend Yield
- PROV 3.53%
- XTNT N/A
- EPS Growth
- PROV N/A
- XTNT N/A
- EPS
- PROV 0.93
- XTNT N/A
- Revenue
- PROV $39,666,000.00
- XTNT $127,766,000.00
- Revenue This Year
- PROV $7.74
- XTNT $13.03
- Revenue Next Year
- PROV $4.06
- XTNT N/A
- P/E Ratio
- PROV $17.04
- XTNT N/A
- Revenue Growth
- PROV 1.90
- XTNT 15.16
- 52 Week Low
- PROV $12.98
- XTNT $0.33
- 52 Week High
- PROV $16.70
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- PROV 56.19
- XTNT 55.72
- Support Level
- PROV $15.59
- XTNT $0.62
- Resistance Level
- PROV $15.89
- XTNT $0.67
- Average True Range (ATR)
- PROV 0.17
- XTNT 0.04
- MACD
- PROV 0.00
- XTNT 0.00
- Stochastic Oscillator
- PROV 63.83
- XTNT 73.80
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.